Home › Prostate Cancer › Wyoming
Prostate Cancer clinical trials in Wyoming
6 studies for Prostate Cancer are looking for participants at sites in Wyoming.
Cities in Wyoming
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Memorial Hospital of Laramie County, Cheyenne
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 13, 2026 · NCT04423211Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Memorial Hospital of Laramie County, Cheyenne
- Billings Clinic-Cody, Cody
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Memorial Hospital of Laramie County, Cheyenne
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT07200830Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Memorial Hospital of Laramie County, Cheyenne
- Billings Clinic-Cody, Cody
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Billings Clinic-Cody, Cody
- Welch Cancer Center, Sheridan
RecruitingPhase 2
Ages 18 and older · Men · Updated Jan 29, 2026 · NCT05806515Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Billings Clinic-Cody, Cody
- Welch Cancer Center, Sheridan
RecruitingPhase 3
Ages 18 and older · Men · Updated Jan 22, 2026 · NCT06470243From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.